GSK-4001785A

N/A

Report date: 2025/02/06 14:52:14

Base Information

Drug NameGSK-4001785A
Drug Alias NamealtSonflex1-2-3 Vaccine(Glaxosmithkline)Shigella vaccine (Glaxosmithkline)Shigella sonnei (Glaxosmithkline)Shigella flexneri 1b, 2a, 3a GMMA vaccine (Glaxosmithkline)GSK4001785A +[6] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumKenya
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcBharat Biotech International Ltd
Inactive CompaniesN/A
Active IndicationsDiarrhea
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A